Coexisting patterns and significance of serum HBV RNA and HBV DNA in patients with treatment-naïve chronic hepatitis B virus infection
AimThe study aimed to explore the coexisting patterns and assess the significance of serum hepatitis B virus (HBV) RNA and traditional virological biomarkers in patients with antiviral treatment-naïve chronic hepatitis B virus (HBV) infection.MethodsSerum HBV RNA, HBV DNA, hepatitis B surface antige...
Saved in:
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2024.1525476/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1841555195511701504 |
---|---|
author | Kun-yan Hao Kun-yan Hao Ye Fan Yi-qing Zhang Yue-cheng Yu |
author_facet | Kun-yan Hao Kun-yan Hao Ye Fan Yi-qing Zhang Yue-cheng Yu |
author_sort | Kun-yan Hao |
collection | DOAJ |
description | AimThe study aimed to explore the coexisting patterns and assess the significance of serum hepatitis B virus (HBV) RNA and traditional virological biomarkers in patients with antiviral treatment-naïve chronic hepatitis B virus (HBV) infection.MethodsSerum HBV RNA, HBV DNA, hepatitis B surface antigen (HBsAg), and hepatitis B envelope antigen (HBeAg) levels were measured and compared in patients with chronic hepatitis B virus infection. The HBV RNA levels were determined using a simultaneous amplification and testing assay.ResultsIn the HBeAg-negative (HBeAg [−]) patients, the serum HBV RNA detectable (HBV RNA [+]) rate (33.33%, 14/42) was significantly lower than the serum HBV DNA detectable (HBV DNA [+]) rate (95.24%, 40/42; p < 0.001). However, there was no significant difference in the HBeAg-positive (HBeAg [+]) patients (p > 0.05). The HBV RNA (+) rate (33.33%, 14/42) was lower in the HBeAg-negative patients than in the HBeAg-positive patients (100%, 17/17, p < 0.001), while the HBV DNA (+) rate (95.24%, 40/42 vs. 94.12%, 16/17) showed no significant difference (p > 0.05). The HBV RNA (+) rates showed a significant difference (p < 0.001) among the different HBsAg levels (10.00, 65.00, 84.21%, p < 0.001), while the HBV DNA (+) rate showed no significant difference (p > 0.05). In all patients, serum HBV RNA correlated well with HBV DNA (r = 0.72, p < 0.001), HBeAg (r = 0.68, p < 0.001), and HBsAg (r = 0.66, p < 0.001). However, the correlations between HBV RNA and other biomarkers varied across the different HBsAg and HBeAg levels.ConclusionThe coexisting patterns of serum HBV RNA and HBV DNA varied with the levels of HBeAg and HBsAg in the patients with treatment-naïve chronic HBV infection. This further suggests that serum HBV RNA should be included in the key index panel to accurately evaluate the natural history of HBV infection and the effects of antiviral treatment. |
format | Article |
id | doaj-art-d33cda7f16c54954a62df1f03f4ea99c |
institution | Kabale University |
issn | 2296-858X |
language | English |
publishDate | 2025-01-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Medicine |
spelling | doaj-art-d33cda7f16c54954a62df1f03f4ea99c2025-01-08T06:11:37ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2025-01-011110.3389/fmed.2024.15254761525476Coexisting patterns and significance of serum HBV RNA and HBV DNA in patients with treatment-naïve chronic hepatitis B virus infectionKun-yan Hao0Kun-yan Hao1Ye Fan2Yi-qing Zhang3Yue-cheng Yu4Center of Hepatology and Department of Infectious Disease, Jinling Hospital Affiliated to School of Medicine, Nanjing University, Nanjing, ChinaState Key Laboratory of Organ Failure Research, Guangdong Province key Laboratory of Viral Hepatitis Research, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, ChinaCenter of Hepatology and Department of Infectious Disease, Jinling Hospital Affiliated to School of Medicine, Nanjing University, Nanjing, ChinaDepartment of Clinical Laboratory, Jinling Hospital Affiliated to School of Medicine, Nanjing University, Nanjing, ChinaCenter of Hepatology and Department of Infectious Disease, Jinling Hospital Affiliated to School of Medicine, Nanjing University, Nanjing, ChinaAimThe study aimed to explore the coexisting patterns and assess the significance of serum hepatitis B virus (HBV) RNA and traditional virological biomarkers in patients with antiviral treatment-naïve chronic hepatitis B virus (HBV) infection.MethodsSerum HBV RNA, HBV DNA, hepatitis B surface antigen (HBsAg), and hepatitis B envelope antigen (HBeAg) levels were measured and compared in patients with chronic hepatitis B virus infection. The HBV RNA levels were determined using a simultaneous amplification and testing assay.ResultsIn the HBeAg-negative (HBeAg [−]) patients, the serum HBV RNA detectable (HBV RNA [+]) rate (33.33%, 14/42) was significantly lower than the serum HBV DNA detectable (HBV DNA [+]) rate (95.24%, 40/42; p < 0.001). However, there was no significant difference in the HBeAg-positive (HBeAg [+]) patients (p > 0.05). The HBV RNA (+) rate (33.33%, 14/42) was lower in the HBeAg-negative patients than in the HBeAg-positive patients (100%, 17/17, p < 0.001), while the HBV DNA (+) rate (95.24%, 40/42 vs. 94.12%, 16/17) showed no significant difference (p > 0.05). The HBV RNA (+) rates showed a significant difference (p < 0.001) among the different HBsAg levels (10.00, 65.00, 84.21%, p < 0.001), while the HBV DNA (+) rate showed no significant difference (p > 0.05). In all patients, serum HBV RNA correlated well with HBV DNA (r = 0.72, p < 0.001), HBeAg (r = 0.68, p < 0.001), and HBsAg (r = 0.66, p < 0.001). However, the correlations between HBV RNA and other biomarkers varied across the different HBsAg and HBeAg levels.ConclusionThe coexisting patterns of serum HBV RNA and HBV DNA varied with the levels of HBeAg and HBsAg in the patients with treatment-naïve chronic HBV infection. This further suggests that serum HBV RNA should be included in the key index panel to accurately evaluate the natural history of HBV infection and the effects of antiviral treatment.https://www.frontiersin.org/articles/10.3389/fmed.2024.1525476/fullHBV RNAHBV DNAHBsAgHBeAgcoexisting patternstreatment-naïve HBV-infectors |
spellingShingle | Kun-yan Hao Kun-yan Hao Ye Fan Yi-qing Zhang Yue-cheng Yu Coexisting patterns and significance of serum HBV RNA and HBV DNA in patients with treatment-naïve chronic hepatitis B virus infection Frontiers in Medicine HBV RNA HBV DNA HBsAg HBeAg coexisting patterns treatment-naïve HBV-infectors |
title | Coexisting patterns and significance of serum HBV RNA and HBV DNA in patients with treatment-naïve chronic hepatitis B virus infection |
title_full | Coexisting patterns and significance of serum HBV RNA and HBV DNA in patients with treatment-naïve chronic hepatitis B virus infection |
title_fullStr | Coexisting patterns and significance of serum HBV RNA and HBV DNA in patients with treatment-naïve chronic hepatitis B virus infection |
title_full_unstemmed | Coexisting patterns and significance of serum HBV RNA and HBV DNA in patients with treatment-naïve chronic hepatitis B virus infection |
title_short | Coexisting patterns and significance of serum HBV RNA and HBV DNA in patients with treatment-naïve chronic hepatitis B virus infection |
title_sort | coexisting patterns and significance of serum hbv rna and hbv dna in patients with treatment naive chronic hepatitis b virus infection |
topic | HBV RNA HBV DNA HBsAg HBeAg coexisting patterns treatment-naïve HBV-infectors |
url | https://www.frontiersin.org/articles/10.3389/fmed.2024.1525476/full |
work_keys_str_mv | AT kunyanhao coexistingpatternsandsignificanceofserumhbvrnaandhbvdnainpatientswithtreatmentnaivechronichepatitisbvirusinfection AT kunyanhao coexistingpatternsandsignificanceofserumhbvrnaandhbvdnainpatientswithtreatmentnaivechronichepatitisbvirusinfection AT yefan coexistingpatternsandsignificanceofserumhbvrnaandhbvdnainpatientswithtreatmentnaivechronichepatitisbvirusinfection AT yiqingzhang coexistingpatternsandsignificanceofserumhbvrnaandhbvdnainpatientswithtreatmentnaivechronichepatitisbvirusinfection AT yuechengyu coexistingpatternsandsignificanceofserumhbvrnaandhbvdnainpatientswithtreatmentnaivechronichepatitisbvirusinfection |